Credit Agricole S A Lowered Enel Generacion Chile S A (EOC) Stake By $23.48 Million, Theravance Biopharma Ord (TBPH) Sellers Increased By 3.33% Their Shorts

May 10, 2017 - By Stephen Andrade

Theravance Biopharma Ord (NASDAQ:TBPH) had an increase of 3.33% in short interest. TBPH’s SI was 5.93M shares in May as released by FINRA. Its up 3.33% from 5.74M shares previously. With 240,300 avg volume, 25 days are for Theravance Biopharma Ord (NASDAQ:TBPH)’s short sellers to cover TBPH’s short positions. The SI to Theravance Biopharma Ord’s float is 19.25%. About 112,571 shares traded. Theravance Biopharma Inc (NASDAQ:TBPH) has risen 10.19% since October 3, 2016 and is uptrending. It has underperformed by 0.71% the S&P500.

Credit Agricole S A decreased Enel Generacion Chile S A (EOC) stake by 64.07% reported in 2016Q4 SEC filing. Credit Agricole S A sold 1.24 million shares as Enel Generacion Chile S A (EOC)’s stock 0.00%. The Credit Agricole S A holds 693,000 shares with $13.47M value, down from 1.93M last quarter. Enel Generacion Chile S A now has $6.55B valuation. The stock rose 1.98% or $0.46 reaching $23.66. About 90,111 shares traded. Enel Generacion Chile SA (ADR) (NYSE:EOC) has risen 6.00% since April 10, 2017 and is uptrending. It has underperformed by 4.91% the S&P500.

Credit Agricole S A increased Terreno Rlty Corp (NYSE:TRNO) stake by 16,555 shares to 35,583 valued at $1.01 million in 2016Q4. It also upped Gulfport Energy Corp (NASDAQ:GPOR) stake by 21,993 shares and now owns 46,398 shares. Grainger W W Inc (NYSE:GWW) was raised too.

Theravance Biopharma, Inc. is a biopharmaceutical company. The company has market cap of $2.19 billion. The Firm is engaged in creating medicines for patients suffering from serious illness. It currently has negative earnings. The Firm operates in the segment of discovery , development and commercialization of human therapeutics.

Among 7 analysts covering Theravance Biopharma (NASDAQ:TBPH), 6 have Buy rating, 1 Sell and 0 Hold. Therefore 86% are positive. Theravance Biopharma had 8 analyst reports since August 12, 2015 according to SRatingsIntel. As per Wednesday, December 21, the company rating was initiated by Needham. Guggenheim initiated the stock with “Buy” rating in Monday, June 20 report. Leerink Swann initiated the shares of TBPH in report on Thursday, May 12 with “Outperform” rating. As per Wednesday, August 12, the company rating was maintained by Robert W. Baird. The stock has “Overweight” rating by Piper Jaffray on Thursday, November 3. Evercore initiated the stock with “Buy” rating in Monday, August 29 report. Robert W. Baird downgraded Theravance Biopharma Inc (NASDAQ:TBPH) rating on Wednesday, October 12. Robert W. Baird has “Underperform” rating and $24 target.

Investors sentiment increased to 1.73 in Q4 2016. Its up 0.02, from 1.71 in 2016Q3. It improved, as 20 investors sold Theravance Biopharma Inc shares while 13 reduced holdings. 19 funds opened positions while 38 raised stakes. 31.87 million shares or 27.84% more from 24.93 million shares in 2016Q3 were reported. Credit Suisse Ag, a Switzerland-based fund reported 47,188 shares. Jpmorgan Chase And accumulated 90,976 shares or 0% of the stock. California State Teachers Retirement System invested 0.01% in Theravance Biopharma Inc (NASDAQ:TBPH). Tower Capital Limited Liability Corp (Trc), New York-based fund reported 83 shares. Foundation Asset Mngmt L P accumulated 509,083 shares. Fmr Lc reported 5.57 million shares stake. Franklin Res has 0.01% invested in Theravance Biopharma Inc (NASDAQ:TBPH). The Texas-based Next Financial Group Incorporated has invested 0% in Theravance Biopharma Inc (NASDAQ:TBPH). Sei invested in 8 shares. Hsbc Public Limited Co holds 0% or 6,914 shares. 12,248 were accumulated by Zacks Mngmt. Proshare Advsrs Llc invested in 40,760 shares or 0.01% of the stock. Rock Springs Cap Limited Partnership holds 1.28% in Theravance Biopharma Inc (NASDAQ:TBPH) or 600,000 shares. Citigroup, New York-based fund reported 18,585 shares. Rhumbline Advisers holds 40,824 shares or 0% of its portfolio.